Greeneria uvicola
Greeneria uvicola
Description
Greeneria uvicola is a destructive phytopathogenic fungus belonging to the kingdom Fungi, class Coelomycetes. This organism is the causal agent of bitter rot of grapes, a significant disease that can devastate vineyard yields, particularly in warm and humid viticultural regions across the globe.
The primary hosts for this pathogen are grapevines. The disease manifests itself on berries, clusters, and shoots. As the berries begin to ripen, they develop reddish-brown lesions that eventually turn into shriveled, mummified fruits covered with black, protruding acervuli (pycnidia). These structures are filled with masses of spores that facilitate the spread of the fungus.
The life cycle of Greeneria uvicola is highly dependent on environmental conditions. The fungus overwinters as mycelium in infected grape clusters, mummified berries, or on the surface of the vine bark. During spring, favorable weather triggers the production of conidia, which are then disseminated by rain splashes, wind, or insects to susceptible host tissues, initiating new infections.
Optimal conditions for disease development include high relative humidity and temperatures ranging from 20°C to 30°C. The pathogen is most harmful during the late stages of berry maturation, especially during rainy seasons. The infection spreads rapidly through clusters, causing the fruit to develop a distinct bitter taste and making the entire crop unsuitable for winemaking or fresh consumption.
Integrated pest management is essential to control the spread of bitter rot. Effective strategies include:
- Strict sanitation by removing and destroying all infected grape clusters and plant debris.
- Improving canopy management to enhance airflow and sunlight penetration, which helps keep the clusters dry.
- Application of targeted fungicide programs during periods of high disease pressure.
- Selecting less susceptible varieties for planting in areas with high humidity and high disease incidence.
Вызывает болезни · 1
Discussion
No discussions yet — be the first.